[1. C. L. Bowlus, M.E.Gershwin – The Diagnosis of Primary Biliary Cirrhosis, Autoimmunity Reviews, Volume 13, Issues 4 – 5, April – May 2014, pg.441 - 444.10.1016/j.autrev.2014.01.041398774524424173]Open DOISearch in Google Scholar
[2. S. C. Hauser, D. S. Pardi, J. J. Poterucha – Mayo Clinic Gastroenterology and Hepatology Board Review, Third Edition, Mayo Clinic Scientific Press And Informa Healthcare USA, Inc, 2008, Rochester, MN, pg.377-38110.1201/b14432]Search in Google Scholar
[3. K. D. Lindor,M. E. Gershwin, R. Poupon, M. Kaplan, N. V. Bergasa, and E. J. Heathcote – Primary biliary cirrhosis, AASLD Hepatology, AASLD Practice Guidelines, Volume 50, Issue 1, 2009, pg.291 – 308.10.1002/hep.2290619554543]Search in Google Scholar
[4. N. Bekki, S. K. Bae, S. Yoshizawa, A. Shiota, T. Gushima, J. Motoshita, S. Shimoda, Y. Aiba, A. Komori, M. Nakamura, K. Takahashi – A case of primary biliary cirrhosis in a patient with rheumatoid arthritis, Clinical Case Reports 2016; Volume 4, Issue 1, pg. 90–9410.1002/ccr3.449470641026783445]Search in Google Scholar
[5. S. Abraham, S. Begum, D. Isenberg – Hepatic manifestations of autoimmune rheumatic diseases, Annals of the Rheumatic Diseases, 2004, Volume 63, Issue 2, pg.123–129.10.1136/ard.2002.001826175490114722198]Open DOISearch in Google Scholar
[6. C. Caramella, J. Avouac, Ph. Sogni, X. Puéchal, A. Kahan, Y. Allanore – Case report: Association between rheumatoid arthritis and primary biliary cirrhosis, Joint Bone Spine 2007, 74(3), pg.279 – 28110.1016/j.jbspin.2006.06.01217369071]Open DOISearch in Google Scholar
[7. Reumatológia Jegyzet, Prof.Dr.Lia Georgescu, Litografia UMF Tirgu Mures, 2010, pg. 152 – 170]Search in Google Scholar
[8. S. Gonzaler-Roces, M. V. Alvarez,S. Gonzalez, A. Dieye, H. Makni, 0. G. Woodfield, L. Housan, V. Konenkov, M. C. Abbadi, N. Grunneta, E. Cotol, C. Lopez-tarreal - HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis, Tissue Antigens, Volume 49,Issue 2,1997, pg. 116–123.10.1111/j.1399-0039.1997.tb02724.x9062966]Search in Google Scholar
[9. C.A. Vargas, R. Medina, C.E. Rubio, E.A. Torres – Primary biliary cirrrhosis associated with Ankylosing spondylitis, Journal of Clinical Gastroenterology, 1994, 18(3), pg.263 – 264.10.1097/00004836-199404000-000328034941]Open DOISearch in Google Scholar
[10. J. Zochling, D. van der Heijde, R. Burgos-Vargas, E. Collantes, J. C. Davis Jr, B. Dijkmans, M. Dougados, P. Ge´her, R. D. Inman, M. A. Khan, T. K. Kvien, M. Leirisalo- Repo, I. Olivieri, K. Pavelka, J. Sieper, G. Stucki, R. D. Sturrock, S. van der Linden, D. Wendling, H. Bo¨hm, B. J. van Royen, J. Braun – ASAS/EULAR recommendations for themanagement of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2006;65(4), pg:442 – 452.]Search in Google Scholar
[11. J. Braun, R. van den Berg, X. Baraliakos, H. Boehm, R. Burgos-Vargas, E. Collantes-Estevez, H. Dagfi nrud, B. Dijkmans, M. Dougados, P. Emery, P. Geher, M. Hammoudeh, R.D. Inman, M. Jongkees, M.A. Khan, U. Kiltz, T.K. Kvien, M. Leirisalo-Repo,W.P. Maksymowych, I. Olivieri, K. Pavelka, J. Sieper, E. Stanislawska-Biernat, D. Wendling, S. Özgocmen, C van Drogen, B.J. van Royen, D. van der Heijde - 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2011;Volume 70, Issue 6, pg.896 – 904.10.1136/ard.2011.151027308605221540199]Search in Google Scholar
[12. C.L. Kohema, A. B. Bortoluzzob, C. R. Gonçalvesc, J. A. Braga da Silvad, A. C. Ximenese, M. B. Bértolo f, S.L.E. Ribeirog, M. Keisermanh, R. Menini, T. L. Skarej, S. Carneirok, V. F. Azevedol, W. P. Vieiram, E. N. Albuquerquen, W. A. Bianchio, R. Bonfigliolip, C. Campanholoq, H. M. S. Carvalhor, I. Pereira da Costas, A. L. B. Pinto Duartet, N. H. Leiteu, S. A. L. Limaw, E. S. Meirellesx, I. A. Pereiray, M. M. Pinheiroz, E. Polito, G. G. Resende, F. A. C. Rocha, M. B. Santiago,M. de Fátima L. C. Sauma, V. Valim, P. D. Sampaio-Barros - Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides, Revista Brasileira de Reumatologia, 2013, 54(1), pg.33 – 37.10.1016/j.rbre.2014.02.004]Search in Google Scholar
[13. S. L. Taffet, K. M. Das – Sulfasalazine. Adverse effects desensitization, 1983, Volume 28, Issue 9, pg. 833 – 842.10.1007/BF012969076136396]Search in Google Scholar
[14. G. P. Aithal - Hepatotoxicity related to antirheumatic drugs, Nature Reviews Rheumatology, 2011, Volume 7, pg. 139 – 150.10.1038/nrrheum.2010.21421263458]Open DOISearch in Google Scholar
[15. A. Pandit, T. Sachdeva, P. Bafna – Drug – Induced Hepatotoxicity: A Review, Journal of Applied Pharmaceutical Science 2012, 02 (05); pg.233-24310.7324/JAPS.2012.2541]Search in Google Scholar
[16. P. Jobanputra, R. Amarasena, F. Maggs, D. Homer, S. Bowman, E. Rankin, A. Filer, K. Raza, R. Jubb - Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events, BMC Musculoskeletal Disorders 2008, 9:48.10.1186/1471-2474-9-48232963218405372]Search in Google Scholar
[17. R. Ionescu – Esenţialul în reumatologie, capitolul Spondilita anchilozantă, ed.Amaltea, Bucureşti, 2007, pg.281 – 292.]Search in Google Scholar
[18. Szekanecz Z. – Reumatológiai gyógyszeres terápia, EdituraMedicina, Budapesta, 2009, pg. 75 – 76.]Search in Google Scholar